FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing carboplatin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing carboplatin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only carboplatin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing amsacrine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Amsacrine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing doxorubicin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing doxorubicin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely doxorubicin hydrochloride 10 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Doxorubicin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only doxorubicin liposome (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only doxorubicin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only doxorubicin liposome in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing daunorubicin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing daunorubicin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely daunorubicin (as daunorubicin hydrochloride) 5 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely daunorubicin (as daunorubicin hydrochloride) 20 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Daunorubicin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only daunorubicin liposome (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only daunorubicin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only daunorubicin liposome in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing denileukin diftitox (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only denileukin diftitox (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only decitabine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Decitabine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely decitabine 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing decitabine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing decitabine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing cedazuridine and decitabine (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only cedazuridine and decitabine in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cedazuridine 100 milligram and decitabine 35 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only cedazuridine and decitabine (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing cedazuridine and decitabine in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing elotuzumab (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Elotuzumab Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing mitoxantrone Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mitoxantrone Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only mitotane in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mitotane Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely mitotane 500 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing mitotane Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing mitotane in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing mitomycin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only mitomycin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mitomycin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely mitomycin 40 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely mitomycin 5 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mitomycin 40mg powder for intravesical solution vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely mitomycin 20 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely mitomycin 10 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely mitomycin 2 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing mitomycin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only mogamulizumab in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mogamulizumab Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing mogamulizumab (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing mogamulizumab in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only midostaurin in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Midostaurin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing midostaurin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing midostaurin in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely midostaurin 25 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing melphalan Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only melphalan in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only melphalan in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Melphalan Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely melphalan 2 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely melphalan (as melphalan hydrochloride) 50 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing melphalan in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing melphalan in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing fluorouracil Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing fluorouracil in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only fluorouracil in cutaneous dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only fluorouracil in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only fluorouracil in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fluorouracil (as fluorouracil sodium) 25 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fluorouracil (as fluorouracil sodium) 50 milligram/1 milliliter conventional release solution for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fluorouracil (as fluorouracil sodium) 50 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only epinephrine and fluorouracil (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fluorouracil 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fluorouracil 50 milligram/1 gram conventional release cutaneous cream Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fluorouracil 250 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fluorouracil 10 milligram/1 gram conventional release cutaneous cream Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fluorouracil 5 milligram/1 gram conventional release cutaneous cream Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing epinephrine and fluorouracil Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing fluorouracil (18-F) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing fluorouracil in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing fluorouracil in cutaneous dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing dasatinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only dasatinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Dasatinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely dasatinib 20 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely dasatinib 50 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely dasatinib 70 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing dasatinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing floxuridine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only floxuridine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only floxuridine (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier

Start Previous Page 8 of 26 Next End

This concept is not in any reference sets

Back to Start